Smartkarma: ECM Coverage Weekly Update (5 August 2017)

Smartkarma: ECM Coverage Weekly Update (12 August 2017)

Smartkarma: ECM Coverage Weekly Update (20 August 2017)

Smartkarma: ECM Coverage Weekly Update (22 July 2017)

Smartkarma: ECM Coverage Weekly Update (15 July 2017)

Smartkarma: ECM Coverage Weekly Update (8 July 2017)

APAC IPOs & Placements

Zhen Zhou, Toh

Smartkarma

Smartkarma unites the fragmented investment industry, connecting institutional investors, independent research providers, and corporates within a single network.

Research Reinvented

Equity Capital Markets

<p><em>The Smartkarma ECM Team puts out a weekly update on the deals we have covered recently, along with updates for upcoming IPOs.</em></p><div class="content-highlight"><p><a href="https://www.smartkarma.com/entities/23641" target="_blank" data-smartkarma-citation="entities:23641:1">Celltrion Healthcare (091990 KS)</a> made a fantastic debut on Friday, rising 22% above deal price. However, investors should be cognizant about its expensive valuation at current price level, citing <a href="https://www.smartkarma.com/profiles/354" target="_blank" data-smartkarma-citation="accounts:354">Sanghyun Park</a>'s concern about a potential bubble in his insights. <a href="https://www.smartkarma.com/profiles/13" target="_blank" data-smartkarma-citation="accounts:13">Kemp Dolliver, CFA</a> also brought up concerns earlier in April about celltrion's biosimilar, Remicade, which had…</p></div>

The Smartkarma ECM Team puts out a weekly update on the deals we have covered recently, along with updates for upcoming IPOs.Celltrion Healthcare (091990 KS) made a fantastic debut on Friday, rising 22% above deal price. However, investors should be cognizant about its expensive valuation at current price level, citing Sanghyun Park's concern about a potential bubble in his insights. Kemp Dolliver, CFA also brought up concerns earlier in April about celltrion's biosimilar, Remicade, which had…

Smartkarma: ECM Coverage Weekly Update (29 July 2017)